BMRN
NASDAQ · Biotechnology
Biomarin Pharmaceutical Inc
$60.85
+0.94 (+1.57%)
Performance
1D
—
1W
—
1M
—
3M
+15.73%
6M
+5.26%
1Y
+2.34%
YTD
+2.35%
Open$60.46
Previous Close$59.91
Day High$60.87
Day Low$58.89
52W High$66.28
52W Low$49.26
Volume—
Avg Volume1.69M
Market Cap11.58B
P/E Ratio43.07
EPS$1.35
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$54.37
Above
SMA 200
$55.65
Above
RSI (14)
55.1
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
34 analysts
Price Target
+107.8% upside
Current
$60.85
$60.85
Target
$126.44
$126.44
$89.21
$126.44 avg
$194.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.15B | 2.73B | 1.41B |
| Net Income | 340.89M | 265.86M | -2,303,166 |
| Profit Margin | 10.8% | 10.3% | -0.2% |
| EBITDA | 419.02M | 344.95M | -4,073,088 |
| Free Cash Flow | — | — | -1,983,877 |
| Rev Growth | +15.4% | +15.4% | -7.9% |
| Debt/Equity | 0.10 | 0.10 | 0.76 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $244.33 | -0.76% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $403.48 | -1.07% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $129.97 | -1.36% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $767.54 | -0.14% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.83 | -4.76% | 47.7 | 27.52B |